Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 16/20 | 0.71 |
| ▸ | SLC6A3 | Q01959 | 16/20 | 0.71 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.71 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3517519 | 0.83 | SLC6A4 (1.00) | SLC6A4SLC6A3SLC6A2KCNH2 | |
| SCHEMBL12235288 | 0.73 | SLC6A3 (0.71) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL3519817 | 0.71 | SLC6A3 (1.00) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL28452881 | 0.69 | SLC6A4 (0.44) | SLC6A4SLC6A3SLC6A2KCNH2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL1491 | 0.69 | SLC6A4 (0.89) | SLC6A4SLC6A3SLC6A2KCNH2 | |
| Hydrochloric Acid SCHEMBL2293 | 0.69 | SLC6A4 (0.59) | SLC6A4SLC6A3SLC6A2KCNH2 | |
| SCHEMBL27517188 | 0.68 | ALDH1A1 (0.39) | SLC6A4SLC6A3SLC6A2KCNH2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL10669396 | 0.67 | SLC6A3 (0.77) | SLC6A4SLC6A3SLC6A2 | |
| SCHEMBL3518541 | 0.67 | SLC6A3 (1.00) | SLC6A4SLC6A3SLC6A2 | |
| Hydrochloric Acid SCHEMBL2163 | 0.66 | SLC6A3 (0.59) | SLC6A4SLC6A3SLC6A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995021615-A1 | USE OF ARYLCYCLOBUTYLALKYLAMINES FOR THE TREATMENT OF SEIZURES AND NEUROLOGICAL DISORDERS | KNOLL AG (DE) | 1995-08-17 | — | — | WO | claimed |
| WO-1995021615-A1 | USE OF ARYLCYCLOBUTYLALKYLAMINES FOR THE TREATMENT OF SEIZURES AND NEUROLOGICAL DISORDERS | KNOLL AG (DE) | 1995-08-17 | — | — | WO | disclosed |